PPT-Access to antiviral drugs for treating HCV for HIV-positive

AIDS 2016  1822 July 2016  Durban South Africa Babikhina Ksenia Treatment Preparedness Coalition officeitpcruorg itpcruorg Monitoring of drug procurement since 2010 HCV procurement since 2012. Marie-Louise Vachon, MD, . MSc. Division of . Infectious. . Diseases. Centre Hospitalier Universitaire de Québec. Management of HCV . in Co-Infected Patients. Prevention and counselling. Baseline laboratory testing. HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Trial. Phase . 3. Sulkowski. MS, et al. JAMA. 2014;312:353-61.. Treatment. Naïve and Treatment . Experienced. HIV Coinfection. Source: . Sulkowski. MS, et al. JAMA. 2014;312:353-61.. Prevalence. . among. . People. . Who. . Inject. . Drugs. : . Results. . from. . the. . First. . Integrated. Bio-. behavioral. . Survey. . of. PWID . in. Mozambique. Authors. : . Cynthia SEMÁ-BALTAZAR. Co-Infection – Florida, . 2014. . STD and Hepatitis Section in collaboration with HIV/AIDS Section – Surveillance Unit . Division of Disease Control and Health Protection. HIV Disease data from 1981 through December . Presented by: . Fabian Cretu, Beverly-Ann Oliver, Kristina Miclat, Maeryl Sumagang. PHM142. September 25, 2018. PHM142 Fall . 2018. Instructor: . Ms. Maya Latif. Coordinator: Dr. J. Henderson. HIV. Resistance to HCV DAAs: What is the threat level?. HCV Biology is the basis for resistance. HCV biology is the basis for cure. Frequency of Protease Resistance Mutations Prior to Therapy. Emergence of Pre-existing Resistant Variants During Treatment with DAA. 30. 40. 50. 60. 70. 80. 90. 1. 00. 0 . 1. 0. . 20. Days Since. . Infection. HIV RNA. . (plasma). HIV. . Antibody. HIV p24. . Ag. IgM. IgG. FIGURE . 1: LABORATORY . MARKERS . OF HIV. . INFECTION. Co-Infection – Florida, . 2013. . STD and Hepatitis Section in collaboration with HIV/AIDS Section – Surveillance Unit . Division of Disease Control and Health Protection. HIV Disease data from 1981 through December . Dr.. . Nirbhay. Kumar. Asstt. . Professor & Head. Deptt. . of Veterinary Pharmacology & Toxicology. Bihar Veterinary College, Bihar Animal Sciences University, Patna. Viral Chemotherapy. Difficult. Singh B, Huang H, Morton DP, Johnson GP, Gutfraind A, Galvani AP, et al. Optimizing Distribution of Pandemic Influenza Antiviral Drugs. Emerg Infect Dis. 2015;21(2):251-258. https://doi.org/10.3201/eid2102.141024. , 1431 H. Definition:. What are the differences between bacterial and viral infections?. Classification of Antiviral Drugs:. . Note. :. . To understand the classification of antiviral drugs, students should remember the steps that are involved in . Presented by: Thomas E. Burgess, PhD, DABCC, FAACC. March 30, 2018. Version 2.0. Hepatitis C Virus. Hepatitis C virus. (. HCV. ) is a small (55–65 . nm. in size) virus. The hepatitis C virus belongs to the genus . Teri Griep-Langholz, RN, HIV/HCV Program Nurse Case Manager. Siouxland Community Health Center. Sioux City, IA . Beyond the Yellow Brick Road—Incorporating HCV into HIV Treatment Model. Learning Objectives. Background. Seasonal influenza is estimated to cause approximately 300,000 to 650,000 deaths worldwide annually. Currently, recommended antiviral agents for influenza (. oseltamivir. ) have not been studied in placebo controlled randomised trials to demonstrate survival benefit in hospitalized patients with influenza.